NXI Therapeutics AG
Company

NXI Therapeutics AG

Biotechnology Research 10.094, Ch 5 employees
Employees
5
Contacts
2
Emails
2

NXI Therapeutics AG Overview

Headquarters
10.094, Ch
Industry
Biotechnology Research
Employees
5
Founded
2021
Funding
4.0M
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About NXI Therapeutics AG

NXI therapeutics focuses on the research and development of a new generation of selective immunosuppressive drugs for autoimmune diseases and transplantations - with objectives of high efficacy, good safety without adverse effects as seen with conventional immunosuppressants.

NXI Therapeutics AG Contact Details

People in AeroLeads
4
With contact data
2
Email contacts
2
50.0% coverage

NXI Therapeutics AG Org Chart

Sample employees and titles
Name Title Contact
Rajesh Jayachandran, Md Phd Chief Scientific Officer, Nxi
View
Ruben Herrendorff CEO at Nxi Therapeutics
Email
Reto Erni Nxi Therapeutics Ag/university of Basel
View
Zoltan Czigler
Email

Employees by Management Level

Executive 2 profiles
Individual contributor 1 profile

Compare Similar Companies to NXI Therapeutics AG